{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:26:18Z","timestamp":1771363578750,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"DOI":"10.1007\/s10856-025-06930-2","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:19:01Z","timestamp":1756279141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study of the release kinetics of dalbavancin from bone allografts"],"prefix":"10.1007","volume":"36","author":[{"given":"Roger","family":"Erivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Bourzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouloud","family":"Yessaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Villatte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"descamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Boisgard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8086-7517","authenticated-orcid":false,"given":"Philip","family":"Chennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"6930_CR1","unstructured":"Masson E. & EM-Consulte. [cited 2023 Apr 24]. Physiopathologie des infections ost\u00e9oarticulaires. Available from: https:\/\/www.em-consulte.com\/article\/1497743\/physiopathologie-des-infections-osteoarticulaires."},{"key":"6930_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1302\/0301-620X.89B5.19039","volume":"89","author":"C Delloye","year":"2007","unstructured":"Delloye C, Cornu O, Druez V & Barbier O. Bone allografts: what they can offer and what they cannot. J Bone Joint Surg Br. 2007;89:574\u20139.","journal-title":"J Bone Joint Surg Br"},{"key":"6930_CR3","doi-asserted-by":"crossref","unstructured":"Erivan R, Villatte G, Ollivier M, Descamps S & Boisgard S. Update on the supply and use of allografts in locomotor system pathologies in France. Orthop Traumatol Surg Res. 2018;104:1125\u201330.","DOI":"10.1016\/j.otsr.2018.06.015"},{"key":"6930_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","volume":"81","author":"AK Thabit","year":"2019","unstructured":"Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO & Alhejaili SF. Antibiotic penetration into bone and joints: an updated review. Int J Infect Dis. 2019;81:128\u201336.","journal-title":"Int J Infect Dis"},{"key":"6930_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/17453670510041457","volume":"76","author":"E Wits\u00f8","year":"2005","unstructured":"Wits\u00f8 E, Persen L, Benum P & Bergh K. Cortical allograft as a vehicle for antibiotic delivery. Acta Orthop. 2005;76:481\u20136.","journal-title":"Acta Orthop"},{"key":"6930_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10561-019-09806-2","volume":"21","author":"R Erivan","year":"2020","unstructured":"Erivan R, Lopez-Chicon P, Fari\u00f1as O, Perez Prieto D, Grau S, Boisgard S, et al. Which type of bone releases the most vancomycin? Comparison of spongious bone, cortical powder and cortico-spongious bone. Cell Tissue Bank. 2020;21:131\u20137.","journal-title":"Cell Tissue Bank"},{"key":"6930_CR7","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.2106\/JBJS.E.01126","volume":"88","author":"WA Jiranek","year":"2006","unstructured":"Jiranek WA, Hanssen AD & Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am. 2006;88:2487\u2013500.","journal-title":"J Bone Joint Surg Am"},{"key":"6930_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7150\/jbji.38373","volume":"4","author":"A Peeters","year":"2019","unstructured":"Peeters A, Putzeys G & Thorrez L. Current Insights in the application of bone grafts for local antibiotic delivery in bone reconstruction surgery. J Bone Jt Infect. 2019;4:245\u201353.","journal-title":"J Bone Jt Infect"},{"key":"6930_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10561-006-9010-3","volume":"7","author":"H Winkler","year":"2006","unstructured":"Winkler H, Kaudela K, Stoiber A & Menschik F. Bone grafts impregnated with antibiotics as a tool for treating infected implants in orthopedic surgery \u2013 one stage revision results. Cell Tissue Banking. 2006;7:319\u201323.","journal-title":"Cell Tissue Banking"},{"key":"6930_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10561-025-10164-5","volume":"26","author":"K Dendoncker","year":"2025","unstructured":"Dendoncker K, Putzeys G, Nieuwenhuizen T, Voet P, Lambrecht S, Bertrand M, et al. Struggling with a cefazolin impregnation protocol of bone chips. Cell Tissue Bank. 2025;26:11.","journal-title":"Cell Tissue Bank"},{"key":"6930_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jbm.b.32993","volume":"102","author":"J Barckman","year":"2014","unstructured":"Barckman J, Baas J, Sorensen M, Lange J, Bechtold JE & Soballe K. Does tobramycin impregnation of allograft bone affect implant fixation? - an experimental study in 12 dogs. J Biomed Mater Res B Appl Biomater. 2014;102:173\u201380.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"6930_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/00016470310017884","volume":"74","author":"MA Buttaro","year":"2003","unstructured":"Buttaro MA, Gonz\u00e1lez Della Valle AM, Pi\u00f1eiro L, Mocetti E, Morandi AA & Piccaluga F. Incorporation of vancomycin-supplemented bone incorporation of vancomycin-supplemented bone allografts: radiographical, histopathological and immunohistochemical study in pigs. Acta Orthop Scand. 2003;74:505\u201313.","journal-title":"Acta Orthop Scand"},{"key":"6930_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/AAC.00741-10","volume":"55","author":"C Ketonis","year":"2011","unstructured":"Ketonis C, Barr S, Adams CS, Shapiro IM, Parvizi J & Hickok NJ. Vancomycin bonded to bone grafts prevents bacterial colonization. Antimicrob Agents Chemother. 2011;55:487\u201394.","journal-title":"Antimicrob Agents Chemother"},{"key":"6930_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-022-05802-y","volume":"23","author":"PH Chou","year":"2022","unstructured":"Chou PH, Lin HH, Yao YC, Chang MC, Liu CL & Wang ST. Does local vancomycin powder impregnated with autogenous bone graft and bone substitute decrease the risk of deep surgical site infection in degenerative lumbar spine fusion surgery?\u2014An ambispective study. BMC Musculoskeletal Disorders. 2022;23:853.","journal-title":"BMC Musculoskeletal Disorders"},{"key":"6930_CR15","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1007\/s00167-022-06885-9","volume":"30","author":"DTS Koh","year":"2022","unstructured":"Koh DTS & Lee KH. Vancomycin-soaked femoral head allograft in opening wedge high tibia osteotomy enables earlier postoperative recovery and reduces infection rates compared to allogenic bone chips. Knee Surg Sports Traumatol Arthrosc. 2022;30:4054\u201362.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"6930_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1179\/joc.2008.20.5.645","volume":"20","author":"K Kanellakopoulou","year":"2008","unstructured":"Kanellakopoulou K, Sahinides T, Tsaganos T, Galanakis N, Giamarellou H & Giamarellos-Bourboulis EJ. In vitro release of fusidic acid and teicoplanin from cancellous bone allografts. J Chemother. 2008;20:645\u20137.","journal-title":"J Chemother"},{"key":"6930_CR17","doi-asserted-by":"publisher","first-page":"fux053","DOI":"10.1093\/femsre\/fux053","volume":"42","author":"J Bengtsson-Palme","year":"2018","unstructured":"Bengtsson-Palme J, Kristiansson E & Larsson DGJ. Environmental factors influencing the development and spread of antibiotic resistance. FEMS Microbiol Rev. 2018;42:fux053.","journal-title":"FEMS Microbiol Rev"},{"key":"6930_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/459867","volume":"2014","author":"I Horny\u00e1k","year":"2014","unstructured":"Horny\u00e1k I, Mad\u00e1csi E, Kalugyer P, V\u00e1cz G, Horv\u00e1thy DB, Szendr\u0151i M, et al. Increased release time of antibiotics from bone allografts through a novel biodegradable coating. Biomed Res Int. 2014;2014:459867.","journal-title":"Biomed Res Int"},{"key":"6930_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10856-014-5344-8","volume":"26","author":"DC Cora\u00e7a-Huber","year":"2015","unstructured":"Cora\u00e7a-Huber DC, Wurm A, Fille M, Hausdorfer J, Nogler M, Vogt S, et al. Antibiotic-loaded calcium carbonate\/calcium sulfate granules as co-adjuvant for bone grafting. J Mater Sci Mater Med. 2015;26:19.","journal-title":"J Mater Sci Mater Med"},{"key":"6930_CR20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.21873\/invivo.13987","volume":"39","author":"M Barbeck","year":"2025","unstructured":"Barbeck M, Zhang J, Stojanovic S, Radenkovic M, Najman S, Foth A, et al. PLLA coating of lyophilized human bone allograft for long-term release of antibiotics. In Vivo. 2025;39:1879\u201390.","journal-title":"In Vivo"},{"key":"6930_CR21","unstructured":"PubChem. Dalvance [Internet]. [cited 2024 Feb 12]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/23724878."},{"key":"6930_CR22","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1128\/AAC.04550-14","volume":"59","author":"MW Dunne","year":"2015","unstructured":"Dunne MW, Puttagunta S, Sprenger CR, Rubino C, Van Wart S & Baldassarre J. Extended-duration dosing and distribution of dalbavancin into bone and articular tissue. Antimicrob Agents Chemother. 2015;59:1849\u201355.","journal-title":"Antimicrob Agents Chemother"},{"key":"6930_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3390\/antibiotics10091129","volume":"10","author":"L Brescini","year":"2021","unstructured":"Brescini L, Della Martera F, Morroni G, Mazzanti S, Di Pietrantonio M, Mantini P, et al. Use of Dalbavancin in Skin, bone and joint infections: a real-life experience in an Italian center. Antibiotics. 2021;10:1129.","journal-title":"Antibiotics"},{"key":"6930_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02280-18","volume":"63","author":"L Morata","year":"2019","unstructured":"Morata L, Cobo J, Fern\u00e1ndez-Sampedro M, Guisado Vasco P, Ruano E, Lora-Tamayo J, et al. Safety and efficacy of prolonged use of Dalbavancin in bone and joint infections. Antimicrob Agents Chemother. 2019;63:e02280-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"6930_CR25","first-page":"e02260","volume":"65","author":"PG Cojutti","year":"2023","unstructured":"Cojutti PG, Rinaldi M, Zamparini E, Rossi N, Tedeschi S, Conti M, et al. Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections. Antimicrob Agents Chemother. 2023;65:e02260\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"6930_CR26","unstructured":"QR1 Guideline.pdf [Internet]. [cited 2024 Feb 12]. Available from: https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29%20Guideline.pdf."},{"key":"6930_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jpba.2007.06.013","volume":"45","author":"P Hubert","year":"2007","unstructured":"Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Chiap P, Cohen N. et al.Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal-part II.J Pharm Biomed Anal. 2007;45:70\u201381.","journal-title":"J Pharm Biomed Anal"},{"key":"6930_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpba.2007.06.032","volume":"45","author":"P Hubert","year":"2007","unstructured":"Hubert P, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Cohen N, Compagnon PA, et al. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal-part III. J Pharm Biomed Anal. 2007;45:82\u201396.","journal-title":"J Pharm Biomed Anal"},{"key":"6930_CR29","doi-asserted-by":"crossref","unstructured":"Plaidy P, Bouattour Y, Yessaad M, Sautou V & Chennell P. Long-term physicochemical stability study of novel ophthalmic formulations combining ceftazidime and vancomycin with and without cyclodextrins. Pharmaceutical Technol Hospital Pharmacy. 2023;8. Available from: https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pthp-2023-0007\/html.","DOI":"10.1515\/pthp-2023-0007"},{"key":"6930_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2025.117416","volume":"193","author":"AH Hoveidaei","year":"2025","unstructured":"Hoveidaei AH, Mosalamiaghili S, Sabaghian A, Hajiaghajani S, Farsani AS, Sahebi M, et al. Local antibiotic delivery: recent basic and translational science insights in orthopedics. Bone. 2025;193:117416.","journal-title":"Bone"},{"key":"6930_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12887-025-05433-x","volume":"25","author":"X Chen","year":"2025","unstructured":"Chen X, Zhuang T, Zou C, Liu Y, Sun Q, Li M, et al. Analysis of antimicrobial resistance and clinical features of Staphylococcus aureus-infected bone and joint infections in children. BMC Pediatr. 2025;25:83.","journal-title":"BMC Pediatr"},{"key":"6930_CR32","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/ph16071005","volume":"16","author":"S Lovatti","year":"2023","unstructured":"Lovatti S, Tiecco G, Mul\u00e9 A, Rossi L, Sforza A, Salvi M, et al. Dalbavancin in bone and joint infections: a systematic review. Pharmaceuticals. 2023;16:1005.","journal-title":"Pharmaceuticals"},{"key":"6930_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.artd.2024.101505","volume":"30","author":"LP Alderson","year":"2024","unstructured":"Alderson LP, Sanikommu S, Mears SC, Barnes CL, Stronach BM, Stambough JB, et al. Dalbavancin use in bone and joint infections. Arthroplast Today. 2024;30:101505.","journal-title":"Arthroplast Today"},{"key":"6930_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/jfb14060305","volume":"14","author":"N Bormann","year":"2023","unstructured":"Bormann N, Schmock A, Hanke A, Eras V, Ahmed N, Kissner MS, et al. Analysis of the ability of different allografts to act as carrier grafts for local drug delivery. J Funct Biomater. 2023;14:305.","journal-title":"J Funct Biomater"},{"key":"6930_CR35","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/antibiotics11070969","volume":"11","author":"DC Cora\u00e7a-Huber","year":"2022","unstructured":"Cora\u00e7a-Huber DC, Steixner SJM, Najman S, Stojanovic S, Finze R, Rimashevskiy D, et al. Lyophilized human bone allograft as an antibiotic carrier: an in vitro and in vivo study. Antibiotics. 2022;11:969.","journal-title":"Antibiotics"},{"key":"6930_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/gels10090593","volume":"10","author":"N Yesbeck","year":"2024","unstructured":"Yesbeck N, Huang D, Carrico C, Madurantakam P & Yang H. Antibiotic-loaded dendrimer hydrogels in periodontal bone regeneration: an in vitro release feasibility study. Gels. 2024 ;10:593.","journal-title":"Gels"},{"key":"6930_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jcis.2025.01.136","volume":"685","author":"X Lu","year":"2025","unstructured":"Lu X, Wan X, Lian J, Peng J, Jing P, Guo Q, et al. Antibiotic-based micelles with bone-targeting and pH-responsive properties for infectious osteomyelitis treatment. J Colloid Interface Sci. 2025;685:648\u201360.","journal-title":"J Colloid Interface Sci"},{"key":"6930_CR38","doi-asserted-by":"crossref","unstructured":"Chang CC, Lo YS, Chen YP, Liu YL & Wang CL. Sequential drug release of self-ordered titania nanotubes with antibacterial function and anticancer ability for bone cancer treatments. Biomed Mater. 2025;20:035021.","DOI":"10.1088\/1748-605X\/adc9ed"},{"key":"6930_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ijpharm.2013.07.014","volume":"455","author":"P Chennell","year":"2013","unstructured":"Chennell P, Feschet-Chassot E, Devers T, Awitor KO, Descamps S & Sautou V. In vitro evaluation of TiO2 nanotubes as cefuroxime carriers on orthopaedic implants for the prevention of periprosthetic joint infections. Int J Pharm. 2013;455:298\u2013305.","journal-title":"Int J Pharm"},{"key":"6930_CR40","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.idnow.2021.06.029","volume":"51","author":"S Baklouti","year":"2021","unstructured":"Baklouti S, Decheiver S, Contardo L, Lelard A, Bouige A, Fourcade C, et al. Concentrations plasmatiques et intra-articulaires de dalbavancine en traitement probabiliste d\u2019infection sur proth\u00e8se articulaire (IPA). Infect Dis Now. 2021;51:S8.","journal-title":"Infect Dis Now"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-025-06930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-025-06930-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-025-06930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T12:10:08Z","timestamp":1767615008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10856-025-06930-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6930"],"URL":"https:\/\/doi.org\/10.1007\/s10856-025-06930-2","relation":{},"ISSN":["1573-4838"],"issn-type":[{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This in-vitro work was funded by the authors\u2019 institution (except for the dalbavancin vials that were provided free of charge by ADVANZ PHARMA). It did not involve human or animal participants. The authors do not have any conflicts of interest (relating directly or indirectly to the study) to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"68"}}